Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-related protein Rab-6A (RAB6A) is a small GTPase belonging to the Rab family, involved in the regulation of vesicular transport processes, particularly trafficking between the Golgi apparatus, endosomes, and the endoplasmic reticulum[1][2][3]. RAB6A localizes to the Golgi and modulates both retrograde (Golgi-to-ER) and anterograde (Golgi-to-plasma membrane) transport, ensuring correct delivery and recycling of proteins[1][2][3]. It binds effectors such as myosin II and specifically interacts with Rabkinesin-6 to modulate microtubule-dependent recycling processes[2][3]. Functional disruption of RAB6A affects Golgi structure and protein secretion, with relevance in several diseases, mainly Cohen syndrome and choroideremia, and implications in viral lifecycle (human cytomegalovirus assembly)[1][2][3]. RAB6A is ubiquitously expressed and is essential for normal vesicle trafficking in eukaryotic cells[3]. Key data illustrated in evidence from genetic, biochemical, and cell biology studies, with no current direct drug targeting or biomarker applications[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related protein Rab-6A (RAB6A).